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Abstract
Background: Cytauxzoonosis is an emerging tick-borne disease of domestic and wild felids. Cytauxzoon felis
induces severe and often fatal disease in domestic cats. In Europe, clinical and subclinical infections caused
by Cytauxzoon sp. are described. We report the first cases of Cytauxzoon sp. infection in domestic cats in
Switzerland.
Methods: Clinical and laboratory data and results of PCR analyses were collected from Cytauxzoon sp. PCR-positive
cats and the cats followed for up to 851 days.
Results: The cases were three two-month old kittens from the same litter (Cases 1–3) and two adult domestic
shorthair cats (Cases 4 and 5). The cats originated from the north-west and west of Switzerland. Cases 1–3
presented with moderate to severe regenerative anaemia and intraerythrocytic inclusions. Cytauxzoon sp. was
confirmed by PCR and sequencing. The kittens made a clinical and haematological recovery after blood transfusion
and/or treatment with azithromycin and atovaquone, but erythroparasitaemia persisted. Case 4 presented with severe
non-regenerative anaemia. Case 5 was healthy and used as a blood donor for Case 4. Following blood transfusion,
Case 4 showed intraerythrocytic inclusions, and Cytauxzoon sp. was confirmed in both Cases 4 and 5 using PCR and
sequencing. Case 4 achieved clinical and haematological remission after treatment with azithromycin, atovaquone and
immunosuppressive drugs. Eight months later, Case 4 was presented again with anaemia but tested Cytauxzoon
sp. PCR-negative. Sequencing of 1637 bp of the 18S rRNA gene of Cytauxzoon sp. revealed 100% nucleotide
sequence identity among isolates of Cases 1–3 and between isolates of Cases 4 and 5, and 99% sequence identity
between isolates of all cases. Phylogenetic analysis revealed the closest relationship of the Swiss isolates to Cytauxzoon
sp. isolates from domestic cats and wild felids from France, Spain and Romania and to Cytauxzoon manul from a
Pallas’s cat.
Conclusions: This is the first report of Cytauxzoon sp. infection in domestic cats in Switzerland. It is also the first
report of infection in very young kittens and transmission of Cytauxzoon sp. to an adult cat by transfusion of
blood from an asymptomatic cat. The cats recovered but some developed chronic asymptomatic
erythroparasitaemia for up to 28 months. Domestic cats may act as reservoirs for Cytauxzoon sp. in Europe and
blood donor cats should be screened for this agent by PCR.
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Background
Cytauxzoonosis is a tick-borne disease caused by the
apicomplexan haemoparasites Cytauxzoon spp. The
best-characterized species, with several genotypes, is
Cytauxzoon felis [1, 2]. Both Dermacentor variabilis and
Amblyomma americanum ticks have been shown to
transmit C. felis in experimental settings [3, 4].
In domestic cats, C. felis infection is generally rapidly
progressive and associated with high mortality. Affected
cats show fever, depression, anorexia, vomiting, pale
mucous membranes, icterus and hepatosplenomegaly.
Clinicopathological signs include non-regenerative
anaemia, leukopenia, thrombocytopenia and hyperbiliru-
binaemia [5]. The schizogonous phase of the organism is
associated with the development of severe clinical dis-
ease in domestic cats. Schizont-laden macrophages
obstruct small vessels in numerous tissues and lead to
circulatory impairment and multi-organ failure [6]. Des-
pite high mortality associated with C. felis infection in
domestic cats, both survival after clinical infection and
subclinical persistent parasitaemia have recently been
documented [7–9]. This may suggest a shift in parasite
vector-host interactions, although the reason for this is
unclear [8, 9]. Chronically infected cats may harbour the
agent for prolonged periods, thereby acting as reservoirs
of C. felis [9, 10]. However, the main natural reservoir of
C. felis in the USA is thought to be the wild bobcat
(Lynx rufus). Infections in this species are most often
subclinical [4, 11, 12], although fatal cytauxzoonosis has
been documented in bobcats, tigers and lions [12–16].
Factors affecting pathogenicity of C. felis in wild felids
are largely unknown. However, the schizogonous phase
in bobcats appears to be short and is rarely associated
with clinical signs [12].
Most reports of cytauxzoonosis are of domestic cats in
the south-eastern, central and mid-Atlantic states of the
USA. Isolates closely related to C. felis have also been doc-
umented in domestic and wild felids in Brazil [17–21].
More recently, infection with other species of Cytauxzoon
spp. in wild and domestic cats has been described. Species
identified in the Eastern Hemisphere include Cytauxzoon
manul in a Pallas’s cat (Felis manul, syn. Otocolobus
manul) [22, 23] and Cytauxzoon sp. in domestic cats,
Eurasian lynx (Lynx lynx) and European wildcats (Felis
silvestris) [24–36]. These isolates were genetically different
from C. felis and were most closely related to C. manul.
Infections with Cytauxzoon-like organisms have also been
described in domestic and wild felids in Iran, Germany
and Zimbabwe [16, 37–39], and most recently in meerkats
(Suricata suricatta) in South Africa [40].
Cytauxzoon sp. is generally considered less virulent in
domestic cats than C. felis, but the clinical significance
of Cytauxzoon sp. infection in domestic cats in Europe
remains unclear. One study found a prevalence of up to
22.9% in cats in northeastern Italy [24], the majority of
which appeared clinically healthy. Indeed, no association
between infection and clinical status, laboratory findings
or mortality was found, and only 7% were anaemic at the
time of diagnosis. Conversely, symptomatic and even fatal
infections have also been documented [24, 30, 31, 41].
These cases presented with a variety of clinical signs,
including lethargy, anorexia, weight loss, pyrexia, pale
mucous membranes, diarrhoea, vomiting and pleural or
peritoneal effusion. In addition, some cats exhibited
clinical signs not typically associated with piroplasm infec-
tions, including stomatitis, ulcerative dermatitis, circling
and vocalizations [24, 31]. However, concomitant diseases,
such as neoplasia, intracranial disorders or feline infec-
tious peritonitis that may cause similar clinical signs were
not always excluded [24, 30].
Here we report the first clinical cases of Cytauxzoon
sp. infection in domestic cats in Switzerland and the
molecular characterization of the isolates. The cases are
three two-month old kittens with symptomatic natural
infection, and an adult cat with suspected blood
transfusion-transmitted infection as well as the asymp-
tomatic blood donor of this cat.
Methods
Inclusion criteria, sample and data collection
Cats were included if they tested PCR-positive for
Cytauxzoon spp. and if the PCR products were se-
quenced and showed > 95% sequence identity with
Cytauxzoon spp. The cases were presented to the Sec-
tion of Small Animal Reproduction, Vetsuisse Faculty,
University of Zurich (Cases 1–3), and to the Small Ani-
mal Clinic of the Vetsuisse Faculty, University of Bern
(Cases 4 and 5). Signalment, medical history, clinical
examination findings, treatment and results of haematol-
ogy, biochemistry, blood smear examination and PCR
analyses were collected (Tables 1, 2, 3 and 4). Four cats
were followed for 851 (Cases 1–3) and 264 (Case 4)
days, respectively.
Haematology and blood biochemistry
Haematology and blood biochemistry were performed at
the Clinical Laboratory, Vetsuisse Faculty, University of
Zurich (Cases 1–3), using a Sysmex XT-2000iV (Sysmex
Corporation, Kobe, Japan) [42] and a Cobas Integra 800
instrument (Roche Diagnostics AG, Rotkreuz, Switzerland),
and at the Clinical Diagnostic Laboratory, Vetsuisse Faculty,
University of Bern (Cases 4 and 5), using an Advia 2120
(Siemens Healthcare AG, Zurich, Switzerland) and a Cobas
c501 (Roche Diagnostics AG), respectively. Haematocrit
and blood biochemistry in Case 5 at first presentation was
measured on a Rapidpoint 400 instrument (Siemens
Healthcare Diagnostics GmbH, Zurich, Switzerland) and
on an IDEXX Vettest Chemistry Analzyer (IDEXX
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Laboratories, Inc., Westbrook, ME, USA). Modified Wright-
Giemsa-stained blood smears (AMES Hema Tek slide
stainer, Bayer, Zurich, Switzerland or Hema-Tek 2000,
Siemens) were made from fresh EDTA-anticoagulated
blood. The Coombs’ test was performed using the microdi-
lution plate method at the Clinical Diagnostic Laboratory,
Vetsuisse Faculty, University of Bern using a commercial
feline Coombs’ reagent (ImmunO, MP Biomedicals Llc.,
Solon, OH, USA). The laboratories’ own and published
reference intervals [43] were used for adult cats and
published reference intervals were used for kittens [44, 45].
Nucleic acid extraction
Total nucleic acid (TNA) extraction was performed from
100 μl of EDTA whole blood with the MagNa Pure LC
(Roche Diagnostics AG) using the MagNa Pure LC TNA
Isolation Kit (Roche Diagnostics AG). A negative control
consisting of 100 μl phosphate-buffered saline was
concurrently prepared with each batch of extractions to
monitor for cross-contamination. Extracted nucleic acids
were stored at -20 °C prior to PCR analyses.
Diagnostic assays
Detection of feline leukaemia virus (FeLV) p27 antigen
and feline immunodeficiency virus (FIV) antibody was
performed using commercial lateral-flow ELISA tests
(SNAP® Kombi Plus FIV/FeLV, IDEXX Diavet AG, Bäch,
Switzerland). Detection of FeLV provirus, Mycoplasma
haemofelis, “Candidatus Mycoplasma haemominutum”
and “Candidatus Mycoplasma turicensis” was performed
using EDTA-anticoagulated blood and species-specific
TaqMan real-time PCR assays [46–48]. For the detection
of Cytauxzoon sp. in EDTA-anticoagulated blood, a
TaqMan real-time PCR assay that amplifies 69 bp of the
18S rRNA gene was used. The assay is based on the fol-
lowing primers and probe: forward primer Cytsp. 1525f
(5'-GAA TGC CTA GTA GAC GCG AGT CA-3'), reverse
primer Cytsp. 1593r (5'-ACG GGC GGT GTG TAC AAA
G-3'), and probe Cytsp. 1549p (5'-FAM- CAG CTC GTG
TCG ATT ACG TCC CTG C-TAMRA-3'). The primers
and probe were designed to specifically detect the 18S rRNA
sequences of Cytauxzoon spp. present in the NCBI Gen-
Bank. The PCR mixture comprised 12.5 μl of 2× qPCRTM
Mastermix (Eurogentec, Seraing, Belgium), 1.125 μl of each
primer and 0.625 μl of the probe, and 5 μl TNA made up to
25 μl with nuclease-free water. Cycling conditions were as
follows: 2 min at 50 °C and 10 min at 95 °C, followed by 45
cycles of 15 s at 95 °C and 1 min at 60 °C. Cycle threshold
(Ct) values were used to estimate the Cytauxzoon sp. burden
in the sample. All real-time PCRs were run on an ABI 7500
Fast Real-Time PCR system (Applied Biosystems, Rotkreuz,
Switzerland). Positive and negative controls that were run
with each assay consisted of DNA from a Cytauxzoon sp.
PCR-positive Iberian lynx (confirmed by sequencing) and of
nuclease-free water, respectively. Cytauxzoon sp. PCR-
positive and follow-up samples were further analysed with a
conventional PCR assay that amplifies 221 bp of the 18S
rRNA gene of Cytauxzoon spp. [35]. Briefly, the assay is
based on the following primers: forward primer Cytfelis.203f
(5'-AGA CCY YAA ACC ATC CCG CT-3') and reverse pri-
mer Cytfelis.423r (5'-CCT GCT GCC TTC CTT AGA TG-
3'). The PCR mixture comprised 2.5 units of Taq DNA
Polymerase (Sigma-Aldrich, Buchs, Switzerland), a final con-
centration of 500 nM of each primer, 200 μM dNTPs
(Sigma-Aldrich), 2.5 μl of 10× PCR Buffer (Sigma-Aldrich),
and 2.5 μl of template made up to a final volume of 25 μl
with nuclease-free water. The thermal cycling conditions
were 95 °C for 5 min, 35 cycles at 95 °C for 30 s, 70 °C for
45 s, and 72 °C for 1 min, and 72 °C for 10 min. The PCR
was run on the Biometra Tpersonal thermal cycler (Biome-
tra, Göttingen, Germany). The PCR products were separated
on a 2% agarose gel and bands of appropriate size (221 bp)
were initially sequenced at a commercial laboratory
(Microsynth AG, Balgach, Switzerland) using the amplifi-
cation primers.
18S rRNA amplification and sequencing
The near complete Cytauxzoon sp. 18S rRNA gene
sequence (1637 bp) was determined for Case 1 on days
7 and 28, for Cases 2 and 3 on days 0 and 28, for Case 4
Table 1 Patient characteristics of the five cats infected with Cytauxzoon sp
Case
number
Date of
presentation
Geographical
location
Outdoor
access
No. of other cats
in household
Breed Gender Age
(months)
Anamnesis Clinical examination findings
1 21.07.14 Montignez yes 2 DSH f 2 Inappetence,
lethargy
Pallor, tachycardia,
tachypnoea
2 22.07.14 Montignez yes 2 DSH m 2 No clinical signs Pallor, tachycardia
3 22.07.14 Montignez yes 2 DSH f 2 No clinical signs Pallor, tachycardia
4 14.11.15 Vallorbe no a 2 DSH f 13 Anorexia, lethargy,
weight loss
Pallor, lethargy, underweight,
tachycardia, tachypnoea, heart
murmur
5 14.11.15 Vallorbe yes 0 DSH mc 28 No clinical signs Unremarkable
Abbreviations: DSH domestic shorthair, f female intact, m male intact, mc male castrated
anot since three-months of age
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on day 5, and for Case 5 on day 24 using published
methods [49]. Briefly, the 18S rRNA gene was amplified
using the forward primer Cytlblynx.23f (5'-GCC ATG
CAT GTC TAA GTA TAA GC-3') and the reverse
primer Cytlblynx.1659r (5'-CGC GCC TAA CGA ATT
AGA AG-3'). The PCR reaction comprised 0.5 μl of
Phusion Hot Start II DNA Polymerase (Thermo Fisher
Scientific, Reinach, Switzerland), 5 μl of HF Phusion
Buffer (Thermo Fisher Scientific), a final concentration
of 0.5 μM of each primer, 0.2 mM dNTPs (Sigma-Al-
drich), and 2.5 μl of template made up to a final volume
of 25 μl with nuclease-free water. The thermal cycling
conditions were 98 °C for 3 min, 35 cycles at 98 °C for
10 s, 56 °C for 30 s, and 72 °C for 1 min, and 72 °C for
10 min. PCR products were separated on a 1.5% agarose
gel and bands of appropriate size (1,637 bp) were cut,
extracted using the MinElute® gel extraction kit (Qiagen
GmbH, Hilden, Germany) and the PCR products were
sequenced. Nucleotide sequences have been submitted
to GenBank under accession numbers MF503141–
MF503148.
Genetic and phylogenetic analyses
Sequences were edited and assembled using Geneious®
v.9.1.7 software (Biomatters Limited, Auckland, New
Zealand) [50]. Phylogenetic analysis was conducted using
MEGA7 [51]. Sequences were aligned to additional
reference sequences retrieved from GenBank using the
Clustal W algorithm. The phylogenetic tree was inferred
using the maximum-likelihood method using a distance
matrix corrected for nucleotide substitutions based on
the Kimura 2-parameter model [52]. Initial tree(s) for
the heuristic search were obtained automatically by
applying neighbour-joining and BioNJ algorithms to a
matrix of pairwise distances estimated using the max-
imum composite likelihood approach, and then selecting
the topology with superior log likelihood value. Codon
positions included were 1st+2nd+3rd+noncoding. All
positions containing gaps and missing data were elimi-
nated. The dataset was resampled 1000 times to generate
bootstrap values [53].
Results
Patient characteristics and geographical location
Details of patient characteristics and geographical locations
of the five cats are shown in Table 1 and Fig. 1. All cases
originated from the north-west or west of Switzerland and
Cases 1–4 lived in multi-cat households. Cases 1–3 were
unvaccinated two-month old siblings that lived in the same
household and had been adopted by an animal welfare
organization at five-weeks of age. At the time of adoption,
Cases 1–3 had severe tick infestation. No data were avail-
able from the queen of these cats. Cases 4 and 5 were adult
cats originating from the same village but living in separate
households. Case 4 was not vaccinated or given preventive
medication against fleas or ticks and lived with two other
cats that were clinically unremarkable. Case 5 was the blood
donor for Case 4 and was a clinically healthy cat with no
previous medical history. Case 5 had not been previously
used as a blood donor and was regularly vaccinated and
given preventive treatment against endo- and ectoparasites.
Anamnesis and clinical examination findings of Cases 1–5
Case 1 was presented because of lethargy, pallor and re-
duced appetite. No signs of illness had been noted in the
siblings, Cases 2 and 3. On clinical examination, all kit-
tens were tachycardic and had pale mucous membranes.
Case 4 was presented with anorexia, lethargy and weight
Table 4 Identification of intraerythrocytic inclusions and PCR results in the five cats infected with Cytauxzoon sp
Parameter Case Day 0
(presentation)
Week 1
(days 1–7)
Week 2
(days 8–14)
Weeks 4–5
(days 22–35)
Week 10
(days 64–70)
Week 17
(days 113–119)
Weeks 38–39
(days 260–273)
Week 122
(days 848–854)
Intraerythrocytic
inclusions
1 positive positive positive na positive positive negative na
2 positive positive positive na positive negative negative na
3 positive positive positive na positive negative negative na
4 negative positive positive negative na na negative na
5 na na na na na na na na
PCR for Cytauxzoon sp.a 1 na positive na positive positive positive positive positive
2 positive positive na positive positive positive positive positive
3 positive positive na positive positive positive positive positive
4 negative positive na positive na na negative na
5 na na na positive na na na na
Note: Cases 1–3 were treated with azithromycin and atovaquone from day 1 to 10 and from day 77 to 86. Case 4 was treated with azithromycin from day 6 to 21
and from day 260 to 270 and with atovaquone from day 11 to 21
Abbreviation: na not applicable
aScreened by real-time PCR and confirmed by conventional PCR and sequencing
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loss. The cat had been referred by the private veterinarian
because of severe anaemia and had been treated once with
hydrocortisone and vitamin K. Upon clinical examination,
Case 4 was underweight and severely lethargic. Marked
pallor, tachycardia, tachypnoea, and a systolic heart mur-
mur were noted. Case 5 was asymptomatic and clinical
examination was unremarkable.
Haematology and biochemistry
Results of haematological and biochemical analyses in the
five cases are detailed in Tables 2 and 3. At presentation,
Cases 1–3 had moderate to severe regenerative anaemia,
and Case 1 had mild leukocytosis. By week 2 (4 days after a
10-day course of therapy), haematology revealed only mild
anaemia (Fig. 2, Table 2). At week 17 (4 weeks after the end
of a second 10-day course of therapy) the haematocrit was
normal in all three cases. Mildly elevated alanine amino-
transferase values (Cases 1 and 3) were evident at week 2.
Case 4 was presented with severe anaemia and
received a whole blood transfusion from Case 5 at
admission. The anaemia was non-regenerative in week 1
and became strongly regenerative in week 2 (Table 2).
Both the haematocrit and reticulocyte counts normal-
ized in week 4, followed by relapse with severe anaemia
in week 38. The Coombs’ test was positive (up to a dilu-
tion of 1:128) at week 1 and negative in weeks 4 and 38.
Besides mild hypokalaemia, no abnormalities were
present in blood biochemistry in Case 4. Case 5 had
normal haematocrit and urea and electrolyte levels at
the time of blood donation and no abnormalities on
haematological examination performed at week 4.
Diagnostic imaging and cytology
Diagnostic imaging and cytology results were available
for Case 4. Thoracic radiographs at admission were
unremarkable. Abdominal ultrasound revealed evidence
of pancreatitis and enteritis in week 1, and mild spleno-
megaly in week 38. Cytological examination of splenic
fine needle aspirates in week 38 revealed extramedullary
haematopoiesis.
Fig. 1 Map of Europe indicating the geographical location of Cases 1–5 and published cases. The geographical location of the present and published
Cytauxzoon sp. cases in domestic cats and wild felids in Europe is indicated with dots and stars, respectively [24–36]. Numbers 1 and 2 indicate the
locations of Cases 1–3 (Montignez, Switzerland) and Cases 4–5 (Vallorbe, Switzerland), respectively (see also Table 1). Two cases in domestic cats for
which the location within the country was not specified in the publication [30, 31] were allocated to the capital city of the country (indicated as open
dots). Abbreviations: PRT, Portugal; ESP, Spain; FRA, France; CH, Switzerland; ITA, Italy; ROU, Romania
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Blood smear examinations
Cases 1–3 showed intraerythrocytic inclusions consist-
ent with Cytauxzoon spp. at first admission and in
the follow-up examinations up to weeks 10–17
(Table 4). These were characterized by a signet-ring
shape with a round thickening of nuclear material at
one point of the ring (Fig. 3). Intraerythrocytic inclu-
sions, consistent with Cytauxzoon spp. were absent in
Case 4 at first admission, but were detected in weeks
1 and 2, five and eleven days after receiving a blood
transfusion from Case 5, respectively (Table 4). In
weeks 4 and 38, intraerythrocytic inclusions were not
detected.
Cytauxzoon sp. PCR
Cases 1–3 tested Cytauxzoon sp. PCR-positive in every
blood sample collected from admission until the end of
the 851-day follow-up period (Table 4). Case 4 tested
PCR-negative for Cytauxzoon sp. at admission, but was
Cytauxzoon sp. PCR-positive five days after receiving a
blood transfusion from Case 5. The cat remained PCR-
positive in week 4, albeit with a marked reduction in
parasitaemia, and was PCR-negative at week 38. Blood
from Case 5 collected five weeks after blood donation
tested PCR-positive for Cytauxzoon sp. No follow-up
was available for this cat.
Results for FeLV, FIV and feline haemoplasmas
Cases 1–5 tested PCR-negative for Mycoplasma haemo-
felis, “Candidatus Mycoplasma haemominutum” and
“Candidatus Mycoplasma turicensis”, and negative for
FIV and FeLV (p27, Cases 1–4; provirus, Cases 4–5).
Treatment, clinical course and outcome
Cases 1–3 were treated twice with atovaquone (15 mg/kg
PO q8h) and azithromycin (10 mg/kg PO q24h) for 10 days
(weeks 1–2 and 11–12, respectively). Case 1 also received a
24 ml whole blood transfusion from a healthy donor cat. In
week 2, the cats were clinically unremarkable and remained
so throughout the 851-day follow-up period.
At admission, Case 4 received a 50 ml whole blood trans-
fusion from Case 5. Treatment with azithromycin (10 mg/
kg PO q24h for 26 days) and atovaquone (15 mg/kg PO
q8h for 11 days) was initiated in weeks 1 and 2, respect-
ively. The cat was also given immunosuppressive treatment
Fig. 2 Course of PCV and Cytauxzoon sp. parasitaemia in Cases 1–3. The PCV (solid lines) and Cytauxzoon sp. parasitaemia (dashed lines) during
133 days following presentation are shown. The time-span during which the cats received medical therapy with atovaquone and azithromycin
(days 1–10 and days 77–86) is indicated with a grey box. The Cytauxzoon sp. parasitaemia is represented by the cycle threshold (Ct) value of the
real-time PCR. The Ct value is inversely proportional to the relative amount of target nucleic acid in the real-time PCR reaction
Fig. 3 Modified Wright-stained blood smear of Case 1. Intraerythrocytic
inclusions with characteristic signet ring-shaped piroplasms consistent
with Cytauxzoon sp. are present in most erythrocytes (examples indicated
by thin arrows). Polychromatophilic red blood cells, supporting
regenerative anaemia, are present (example indicated by a thick arrow).
1000× magnification. Scale-bar: 10 μm
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(prednisolone, 2 mg/kg/d and cyclosporine, 5 mg/kg/d, in
tapering doses over two months), antibiotics (doxycycline,
10 mg/kg/d for 10 days), and gastroprotective and anti-
emetic medication. The cat’s general condition was slightly
improved in week 1, but intermittent fever was noted. In
week 2, the cat was normothermic with a good appetite. In
week 4, the cat was clinically unremarkable but was pre-
sented again in week 38 with lethargy, fever, pallor, tachy-
cardia and severe regenerative anaemia (Table 2). The cat
was treated with azithromycin and immunosuppressive
doses of prednisolone. The cat rapidly improved and was
discharged after five days of hospitalization. Case 4 was
then lost for further follow-up. No treatment was given to
Case 5 and no follow-up data was available from this cat.
Cytauxzoon sp. sequencing
The Cytauxzoon sp. 18S rRNA gene sequences from
Cases 1, 2 and 3 showed 100% sequence identity at all
time points. The Cytauxzoon sp. 18S rRNA gene se-
quences from Cases 4 and 5 also showed 100% sequence
identity. Sequence comparison between isolates from
Cases 1–3 and Cases 4 and 5 showed a single nucleotide
mismatch, resulting in a sequence identity of 99%. The
isolates of Cases 1–5 showed highest sequence identity
with Cytauxzoon sp. isolates from domestic cats from
France (GenBank: EU622908, 99–100% sequence iden-
tity) and Spain (GenBank: AY309956, 99% sequence
identity), and with C. manul from Mongolia (GenBank:
AY485690, 99% sequence identity). Sequence compari-
son revealed only 96% sequence identity with a C. felis
isolate from the USA (GenBank: AY679105). Phylogen-
etic analysis showed that the Swiss isolates clustered
together with European Cytauxzoon sp. isolates from do-
mestic and wild felids, and with C. manul from a Pallas’s
cat (Fig. 4).
Discussion
Since the first report in the mid-1970s [54], feline
cytauxzoonosis caused by C. felis has been considered an
emerging disease with an expanding case distribution
from the south-central to the south-east and mid-
Atlantic regions of the USA [55]. In recent years, infec-
tions with molecularly distinct Cytauxzoon spp. have
been described in domestic cats in Europe, i.e. in Italy,
France, Spain and Portugal [24, 29–31, 36, 41]. The
present report is the first description of cases of Cytaux-
zoon sp. infection in domestic cats in Switzerland. In
agreement with previous European studies, the agent
detected in the five cases was phylogenetically distinct
from C. felis and most closely related to C. manul
[22, 23]. Our results further support the hypothesis that
different Cytauxzoon species or strains exist in different
geographical locations and that the species might differ in
pathogenicity. To further resolve Cytauxzoon taxonomy,
phylogenetic studies based on additional genes (mitochon-
drial genes or whole genome sequencing) should be
performed.
Given that infection of domestic cats with C. felis
occurs in areas with both a natural reservoir host (the
American bobcat) and a tick vector (Amblyomma ameri-
canum or Dermacentor variabilis) [56], similar condi-
tions are likely to exist for Cytauxzoon sp. infections in
Europe. Although reservoirs in Europe have not been
definitively identified, infections in European wildcats in
Italy and Romania [33, 34], in the Iberian lynx in Spain
[28] and in the Eurasian lynx in Romania and
Switzerland ([34], M.L. Meli, personal communication)
are documented. The domestic cats described in the
present report originated from two villages in the north-
west or west of Switzerland. Both villages are located
near the French border and 70–140 km away from Saint
Sauveur (Bourgogne-Franche-Comté region) where a
symptomatic Cytauxzoon sp. infection occurred in a do-
mestic cat in France [31]. The north-west and west of
Switzerland host a stable population of the Eurasian
lynx, reintroduced in Switzerland in the 1970s, and of
the European wildcat [57, 58]. Similar to bobcats serving
as the main reservoir of C. felis in the USA [6], it is
likely that the Eurasian lynx plays a central role as a
reservoir of Cytauxzoon sp. in Switzerland. The role of
the European wildcat as a reservoir of Cytauxzoon sp. is
not clear, but given that they might live in close proxim-
ity and even interbreed with domestic cats [59], a trans-
mission of Cytauxzoon sp. between domestic and wild
cats via ticks seems possible. The tick vector for Cytaux-
zoon sp. in Europe is not known. Ticks of the species
Ixodes spp., Dermacentor spp. and Rhipicephalus spp.
have all been described in Switzerland [60–62] and
could be involved in transmission. All cases in this study
lived in a rural area. An association between Cytauxzoon
sp. infection and living in rural areas and outdoor access
was recently documented in domestic cats in Spain and
Italy, respectively [24, 36].
Cases 1–3 were siblings from the same litter and were
presented at only eight weeks of age. Cytauxzoon sp.
infection was also documented in two six- to seven-
month-old siblings in Italy [41]. Experimental studies
failed to demonstrate perinatal transmission of C. felis in
domestic cats [63]. Since all kittens described in the
present report had severe tick infestation at the time of
adoption, a vector-borne transmission of Cytauxzoon sp.
infection is likely. Unfortunately, clinical data and blood
samples were not available from the queen to exclude
vertical transmission in these cases.
The pathogenesis of Cytauxzoon sp. infection in do-
mestic cats is not fully elucidated but appears to differ
from that caused by C. felis. The latter is generally asso-
ciated with high mortality [64], although asymptomatic
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infections have been described in recent years [7–10].
The acute stage of disease is caused by schizonts, large
structures within mononuclear cells that occlude blood
vessels in various organs and result in circulatory im-
pairment and multiorgan dysfunction. Although the
schizogonous phase has not yet been identified in
Cytauxzoon sp. infected cats [24, 31, 41], it is very likely
that Cytauxzoon sp. also undergoes schizogony given the
molecular phylogeny of Cytauxzoon spp. organisms [65].
In bobcats, the natural reservoir of C. felis, schizogony
does occur but appears to be limited in duration and
rarely causes clinical disease [12].
Both symptomatic and asymptomatic Cytauxzoon sp.
infections have been documented in previous and the
present reports [24, 30, 31, 41]. Besides the blood donor
(Case 5), all cats in the present report showed clinical
signs that could be attributed to Cytauxzoon sp. infec-
tion. As erythroparasitaemia was only observed after
blood transfusion in Case 4, the extent to which infec-
tion with Cytauxzoon sp. contributed to clinical disease
in this cat is unclear. Given the initial negative results
for infectious aetiologies, including Cytauxzoon spp.,
immune-mediated disease was suspected to be the cause
of initial clinical presentation. The positive Coombs’ test
Fig. 4 Molecular phylogenetic analysis by maximum likelihood method of the 18S rRNA gene. The tree with the highest log likelihood (-3233.55)
is shown. The percentage of trees in which the associated taxa clustered together is shown next to the branches. The tree is drawn to scale, with
branch lengths measured in the number of substitutions per site. The analysis involved 42 nucleotide sequences (GenBank accession numbers
are indicated). There were a total of 726 positions in the final dataset
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in Case 4 may reflect a primary immune-mediated dis-
order but may also have been due to previous blood
transfusion. No retroviral or haemoplasma infections
were present in the cats that could have exacerbated
clinical disease. However, Cases 1–4 may have been im-
munocompromised due to young age or immunosup-
pressive therapy, which may have predisposed them to
the development of clinical disease. Similar to previous
reports [24, 30, 31, 41], the cases described herein pre-
sented with nonspecific clinical signs, such as anorexia
and lethargy. On physical examination, pallor, tachyp-
noea and tachycardia were common. Cases 1–3 pre-
sented with regenerative anaemia, but the anaemia was
initially hyporegenerative in Case 4. Other clinicopatho-
logic abnormalities that have been documented in
Cytauxzoon sp. infected cats, including leukocytosis,
thrombocytopenia and hyperbilirubinaemia were incon-
sistently or not present in Cases 1–4 [24, 30, 31, 41].
In Case 4, Cytauxzoon sp. infection was likely the re-
sult of blood transfusion from the asymptomatic in-
fected donor cat (Case 5). Although a false negative PCR
result at first presentation cannot be ruled out, this
seems unlikely given that the blood donor tested PCR-
positive for Cytauxzoon sp. This is the first description
of Cytauxzoon sp. transmission by blood transfusion. For
C. felis, blood transfusion has been shown to induce
severe disease if blood is collected during the schizogen-
ous phase of disease, whereas transfusion from subclin-
ical cats does not induce schizogony or clinical disease
but leads to chronic parasitaemia in the recipient cat
[66]. Because the pathogenesis of Cytauxzoon sp. seems
to differ from C. felis, it is unclear whether transfusion
of blood from Cytauxzoon sp. infected donor cats can
induce clinical disease in recipients.
Case 5 of the present report showed no clinical signs of
disease and no alterations in the complete blood count.
This cat was used as a blood donor, given unremarkable
findings of the clinical examination and negative serologic
tests for FeLV and FIV. Screening potential donors for
Cytauxzoon sp. infection was not considered necessary, as
this infection had not been previously documented in
Switzerland. The consensus statements of the European
Advisory Board on Cat Disease (ABCD) and the American
College of Veterinary Internal Medicine (ACVIM)
recommend that in endemic areas, only PCR-negative cats
should be used as donors [67, 68]. Given the long-term
chronic parasitaemia in most Cytauxzoon sp. infected cats
and severe disease reported in some infected cats,
Cytauxzoon sp. should be included in the screening of
all blood donor cats in central and southern Europe. Such
screening should be done using PCR as blood smear evalu-
ation is poor sensitive to detect low-grade parasitaemia.
Cases 1–3 in this study recovered following treatment
with atovaquone, azithromycin and supportive care.
Treatment with atovaquone (15 mg/kg PO q8h) and
azithromycin (10 mg/kg PO q24h) for 10 days is
regarded the treatment of choice for acute cytauxzoono-
sis caused by C. felis and has been shown to be superior
to treatment with imidocarb diproprionate (3.5 mg/kg
IM twice 7 days apart) [69]. Previously published
Cytauxzoon sp. cases in Europe were treated with a
variety of antiprozotoal drugs [24, 30, 31, 41], but the
optimal treatment strategy for this infection remains
unclear given the lack of controlled studies.
Despite clinical recovery, chronic asymptomatic
parasitaemia was observed in Cases 1–3 even after a
second course of treatment with atovaquone and azi-
thromycin. Similarly, asymptomatic parasitaemia for
up to 1.3 years has been documented in domestic
cats in Europe [24, 31, 41]. The extent to which
asymptomatic cats with chronic Cytauxzoon sp. infec-
tion may act as a reservoir is unclear. For C. felis,
transmission of the agent from chronically infected
domestic cats to naive cats via tick bites has been
documented [3, 70]. This suggests that cats are com-
petent reservoirs for C. felis. Furthermore, a high
prevalence of chronic C. felis infection has recently
been documented in an enzootic area in the USA [9].
The authors concluded that, because domestic cats
are more likely to live near other domestic cats than
near bobcats, these chronically infected cats may play
an important role in disease transmission. The extent
to which this may also be the case for Cytauxzoon sp.
infection remains to be elucidated. However, indoor
housing and ectoparasite control should be consid-
ered for cats chronically infected with Cytauxzoon sp.
In contrast to Cases 1–3, Case 4 seemed to have
cleared erythroparasitaemia when it presented for a re-
lapse of anaemia in week 38. Although to the best of our
knowledge, this has not yet been reported for C. felis in-
fection, clearance of Cytauxzoon sp. infection was
recently documented in a cat in Italy that remained
PCR-negative for 175 days following treatment with dox-
ycyline and imidocarb diproprionate [41]. Although
treatment with atovaquone and azithromycin may have
contributed to clearing erythroparasitaemia in Case 4,
this is not clear because Cytauxzoon sp. was still
detected by PCR immediately following treatment.
Conclusions
The present study further expands the geographical
range of Cytauxzoon sp. infection in domestic cats in
Europe and describes the accidental transmission of
Cytauxzoon sp. by blood transfusion. The report further
emphasizes that Cytauxzoon sp. infection should be
considered in domestic cats in central Europe that are
presented with anaemia. The pathogenesis and route of
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transmission of Cytauxzoon sp. requires further investi-
gation. Given the long-term asymptomatic parasitaemia,
domestic cats may represent an important reservoir for
Cytauxzoon sp. even in areas in which no wild reservoirs
are present, and healthy blood donor cats should be
screened for this agent by PCR.
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